NY-932

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNY-932
Drug Alias Namewound therapy (Namyang)blood cell protectant (Namyang)NY-932
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNamyang Aloe Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNamyang Aloe Co Ltd
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A